A5103133843- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Systemic Sclerosis and Related Diseases
- Mycobacterium research and diagnosis
- Cytokine Signaling Pathways and Interactions
- Epilepsy research and treatment
- Myasthenia Gravis and Thymoma
- Viral Infections and Immunology Research
- Powdery Mildew Fungal Diseases
- Sphingolipid Metabolism and Signaling
University Clinical Centre Maribor
2013-2021
University of Maribor
2013-2021
University Medical Center
2013
University Hospital and Clinics
2013
Splošna Bolnišnica Celje
2001
Multiple sclerosis (MS) is a neurological disorder characterised by inflammatory demyelination and neurodegeneration in the central nervous system (CNS). Until recently, disease modifying treatment was based on agents requiring parenteral delivery, thus limiting long-term compliance. Basic treatments such as beta-interferon provide only moderate efficacy, although therapies for second-line highly active MS are more effective, they associated with potentially severe side effects. Fingolimod...
Abstract Purpose To cross-culturally adapt and validate Multiple Sclerosis Quality of Life-54 (MSQOL-54) instrument. Methods The study which enrolled 134 Slovenian multiple sclerosis (MS) patients was conducted from March to December 2013. internal consistency the MSQOL-54 instrument evaluated by Cronbach’s alpha coefficient (α), its dimensionality assessed principal component analysis (PCA). Results whole had high (α=0.88), as well majority twelve subscales (α=0.83-0.94). results PCA showed...
Summary Prolonged‐release fampridine (fampridine PR ) is a potassium channel blocker that improves conductivity of signal on demyelinated axons in central nervous system. Fampridine has been approved to improve speed walking patients with multiple sclerosis. This statement provides brief summary data and recommendations practical use the medication clinical practice, prediction, evaluation response treatment patient management.
To determine the extent of subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis (RR MS) receiving disease-modifying drugs (DMD).
Introduction: The purpose of the study was to identify possible correlations between quality life, neurological disability, and functional ability in patients with multiple sclerosis.Methods: 258 sclerosis were included cross-sectional study. They assessed Expanded Disability Status Scale (EDSS), Berg Balance (BBS), Timed 25-Foot Walk Test (T25-FW), 9-Hole Peg (9HPT), Paced Auditory Serial Addition (PASAT-3) EQ visual analogue scale (EQ-VAS). Inferential statistics used.Results: A positive...
Purpose: Cerebrospinal fluid (CSF) free light chains (FLC) are of promising diagnostic importance in patients with multiple sclerosis (MS). However, research is required to confirm their utility as part the criteria for MS. In addition, very few publications can be found addressing relationship FLCs clinical presentation at onset We aimed evaluate performance FLC kappa and lambda indices, explored number type functional systems (FS) involved.
 Methods: indices were determined paired CSF...